BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Ducommun
DCO
$2.89B
| $44.7M | ﹤0.01% |
819,117
-17,227
| -2% | -$979K |
|
2777
Peoples Bancorp
PEBO
$1.5B
| $44.7M | ﹤0.01% |
1,508,376
-66,082
| -4% | -$2.15M |
|
2778
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.1B
| $44.4M | ﹤0.01% |
705,518
-63,943
| -8% | -$3.84M |
|
|
LTCH
2779
DELISTED
Latch, Inc. Common Stock
LTCH
| $44.2M | ﹤0.01% |
3,605,904
+661,501
| +22% | +$7.2M |
|
|
IVC
2780
DELISTED
Invacare Corporation
IVC
| $44.2M | ﹤0.01% |
5,477,681
-88,701
| -2% | -$739K |
|
2781
Ascendis Pharma A/S
ASND
$16B
| $44.2M | ﹤0.01% |
335,761
-124,526
| -27% | -$16.6M |
|
2782
Adecoagro
AGRO
$1.34B
| $44.1M | ﹤0.01% |
4,393,786
+2,167,819
| +97% | +$21.6M |
|
|
ESPR
2783
DELISTED
Esperion Therapeutics
ESPR
| $44.1M | ﹤0.01% |
2,085,347
-61,049
| -3% | -$1.47M |
|
|
CFB
2784
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $44.1M | ﹤0.01% |
3,205,827
-76,450
| -2% | -$1.1M |
|
2785
Outdoor Holding Co
POWW
$252M
| $44M | ﹤0.01% |
4,495,001
+3,541,730
| +372% | +$25.2M |
|
2786
Gossamer Bio
GOSS
$86.9M
| $44M | ﹤0.01% |
5,415,805
+50,456
| +0.9% | +$437K |
|
2787
Doximity
DOCS
$3.94B
| $43.7M | ﹤0.01% |
+749,987
| New | +$42.1M |
|
|
RVI
2788
DELISTED
Retail Value Inc. Common Shares
RVI
| $43.5M | ﹤0.01% |
21,809,826
-306,786
| -1% | -$545K |
|
2789
Liberty Latin America Class A
LILA
$1.69B
| $43.5M | ﹤0.01% |
4,623,908
-521,575
| -10% | -$4.95M |
|
|
LAND
2790
Gladstone Land Corp
LAND
$354M
| $43.3M | ﹤0.01% |
1,800,960
+156,400
| +10% | +$3.54M |
|
2791
Alaunos Therapeutics
TCRT
$4.93M
| $43.3M | ﹤0.01% |
109,281
-15,234
| -12% | -$7.11M |
|
2792
Regional Management Corp
RM
$300M
| $43.3M | ﹤0.01% |
929,623
-37,860
| -4% | -$1.64M |
|
2793
Vanguard Real Estate ETF
VNQ
$39.2B
| $43.2M | ﹤0.01% |
424,845
-332,773
| -44% | -$33M |
|
2794
GoodRx Holdings
GDRX
$1.11B
| $43.2M | ﹤0.01% |
1,200,664
-532,143
| -31% | -$19.6M |
|
2795
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $43.2M | ﹤0.01% |
837,953
+122,442
| +17% | +$6.32M |
|
|
VBIV
2796
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $43.2M | ﹤0.01% |
429,423
-32,493
| -7% | -$3.17M |
|
|
PTVE
2797
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $43M | ﹤0.01% |
2,854,410
+48,120
| +2% | +$722K |
|
2798
Driven Brands
DRVN
$2.41B
| $43M | ﹤0.01% |
1,389,780
-458,315
| -25% | -$12.9M |
|
2799
Nkarta
NKTX
$157M
| $42.9M | ﹤0.01% |
1,352,826
-415,796
| -24% | -$12M |
|
2800
Mercantile Bank Corp
MBWM
$1.07B
| $42.8M | ﹤0.01% |
1,416,079
-92,565
| -6% | -$2.95M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.